Walter Reed Army Institute of Research, Division of Regulated Activities, Department of Regulated Laboratories, Silver Spring, MD 20910-7500, United States.
Chem Biol Interact. 2010 Sep 6;187(1-3):191-8. doi: 10.1016/j.cbi.2010.02.015. Epub 2010 Feb 13.
Novel therapeutics to overcome the toxic effects of organophosphorus (OP) chemical agents are needed due to the documented use of OPs in warfare (e.g. 1980-1988 Iran/Iraq war) and terrorism (e.g. 1995 Tokyo subway attacks). Standard OP exposure therapy in the United States consists of atropine sulfate (to block muscarinic receptors), the acetylcholinesterase (AChE) reactivator (oxime) pralidoxime chloride (2-PAM), and a benzodiazepine anticonvulsant to ameliorate seizures. A major disadvantage is that quaternary nitrogen charged oximes, including 2-PAM, do not cross the blood brain barrier (BBB) to treat brain AChE. Therefore, we have synthesized and evaluated pro-2-PAM (a lipid permeable 2-PAM derivative) that can enter the brain and reactivate CNS AChE, preventing seizures in guinea pigs after exposure to OPs. The protective effects of the pro-2-PAM after OP exposure were shown using (a) surgically implanted radiotelemetry probes for electroencephalogram (EEG), (b) neurohistopathology of brain, (c) cholinesterase activities in the PNS and CNS, and (d) survivability. The PNS oxime 2-PAM was ineffective at reducing seizures/status epilepticus (SE) in diisopropylfluorophosphate (DFP)-exposed animals. In contrast, pro-2-PAM significantly suppressed and then eliminated seizure activity. In OP-exposed guinea pigs, there was a significant reduction in neurological damage with pro-2-PAM but not 2-PAM. Distinct regional areas of the brains showed significantly higher AChE activity 1.5h after OP exposure in pro-2-PAM treated animals compared to the 2-PAM treated ones. However, blood and diaphragm showed similar AChE activities in animals treated with either oxime, as both 2-PAM and pro-2-PAM are PNS active oximes. In conclusion, pro-2-PAM can cross the BBB, is rapidly metabolized inside the brain to 2-PAM, and protects against OP-induced SE through restoration of brain AChE activity. Pro-2-PAM represents the first non-invasive means of administering a CNS therapeutic for the deleterious effects of OP poisoning by reactivating CNS AChE.
由于有机磷 (OP) 化学制剂在战争(例如 1980-1988 年的两伊战争)和恐怖主义(例如 1995 年东京地铁袭击事件)中的使用有据可查,因此需要寻找新的治疗方法来克服其毒性作用。美国标准的 OP 暴露治疗包括硫酸阿托品(阻断毒蕈碱受体)、乙酰胆碱酯酶 (AChE) 重激活剂(肟)氯解磷定(2-PAM)和苯二氮䓬类抗惊厥药以改善惊厥。一个主要的缺点是带正电荷的季铵肟,包括 2-PAM,不能穿透血脑屏障 (BBB) 来治疗大脑中的 AChE。因此,我们合成并评估了亲脂性 2-PAM(一种可穿透血脑屏障的 2-PAM 衍生物),它可以进入大脑并重新激活中枢神经系统中的 AChE,防止豚鼠在接触 OP 后发生惊厥。亲脂性 2-PAM 可通过以下方法防止 OP 暴露后发生惊厥:(a) 用于脑电图 (EEG) 的手术植入式无线电遥测探头,(b) 大脑的神经组织病理学,(c) 周围神经系统和中枢神经系统中的胆碱酯酶活性,以及 (d) 存活率。在二异丙基氟磷酸酯 (DFP) 暴露的动物中,周围神经系统肟 2-PAM 无效降低惊厥/癫痫持续状态 (SE)。相比之下,亲脂性 2-PAM 可显著抑制并随后消除惊厥活动。在 OP 暴露的豚鼠中,亲脂性 2-PAM 可显著减少神经损伤,但 2-PAM 无效。与 2-PAM 治疗的动物相比,在亲脂性 2-PAM 治疗的动物中,OP 暴露后 1.5 小时大脑的不同区域表现出明显更高的 AChE 活性。然而,血液和横膈膜在接受两种肟治疗的动物中显示出相似的 AChE 活性,因为 2-PAM 和亲脂性 2-PAM 都是周围神经系统活性肟。总之,亲脂性 2-PAM 可以穿透血脑屏障,在大脑内迅速代谢为 2-PAM,并通过恢复大脑 AChE 活性来防止 OP 引起的 SE。亲脂性 2-PAM 代表了通过重新激活中枢神经系统 AChE 来治疗 OP 中毒对中枢神经系统有害影响的非侵入性治疗方法。